Volume 14 Issue 9, September 2017

Volume 14 Issue 9

Cover image supplied by Carolina Tropini, Sonnenburg Group, Stanford University, USA, who is funded by a James S. McDonnell fellowship. Fluorescent in situ hybridization of mouse colon colonized with gnotobiotic microbiota. Tissue was stained by DAPI and the mucus labelled with UEA-1 (Ulex europaeus agglutinin I), bacteria were labelled with fluorescent DNA probes.

Research Highlights

News and Views

  • News & Views |

    NAFLD, the hepatic manifestation of the metabolic syndrome, is a multifactorial condition — environmental factors influence an inherited genetic risk. Stender et al. now describe the additive effect of obesity and NAFLD-associated genetic polymorphisms on steatosis, elevated serum alanine aminotransferase levels and cirrhosis, remarkably illustrating the principle of gene–environment interactions.

    • Jake P. Mann
    •  & Quentin M. Anstee
  • News & Views |

    Biosimilar monoclonal antibodies are now being accepted in clinical practice by IBD specialists. However, switching patients already undergoing originator biologic treatment to biosimilars has been debated due to lack of controlled studies. The NOR-SWITCH study now provides novel clinical evidence in switching from originator to biosimilar in patients with IBD.

    • Silvio Danese
    •  & Laurent Peyrin-Biroulet

Reviews

  • Review Article |

    The intestinal lymphatic vasculature has a range of functions, from maintenance of interstitial fluid balance to transport of antigens, cells, dietary lipids and fat-soluble vitamins. In this Review, Petrova and Bernier-Latmani provide an in-depth overview of intestinal lymphatics, including their roles in human diseases.

    • Jeremiah Bernier-Latmani
    •  & Tatiana V. Petrova
  • Review Article |

    Increasing evidence suggests that the gut microbiota are important modulators of chronic liver disease progression and the development of hepatocellular carcinoma. In this Review, Yu and Schwabe discuss the mechanisms by which the gut microbiota promote hepatocarcinogenesis, and explore therapeutic interventions with clinical potential.

    • Le-Xing Yu
    •  & Robert F. Schwabe
  • Review Article |

    Owing to its unique composition and influence on numerous biological processes, the extracellular matrix (ECM) is an ideal therapeutic substrate for tissue repair. In this Review, the authors provide an overview of ECM bioscaffolds derived from gastrointestinal tissues, and discuss advances in regenerative medicine using these scaffolds for the reconstruction of functional gastrointestinal tissues.

    • George S. Hussey
    • , Timothy J. Keane
    •  & Stephen F. Badylak